ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men. (EPEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01715636
Recruitment Status : Completed
First Posted : October 29, 2012
Last Update Posted : January 12, 2015
Sponsor:
Information provided by (Responsible Party):
Andrew Carr, St. Vincent's Hospital-Manhattan

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2014
  Actual Study Completion Date : July 2014